240 related articles for article (PubMed ID: 31721773)
1. Management of locally advanced non-small cell lung cancer in the modern era: A national Italian survey on diagnosis, treatment and multidisciplinary approach.
Bruni A; Giaj-Levra N; Ciammella P; Maragna V; Ferrari K; Bonti V; Grossi F; Greco S; Greco C; Borghetti P; Franceschini D; Capelletto E; Perna M; Banna G; Vagge S; Baldini E; Bria E; Botti A; Tiseo M; Paci M; Taraborrelli M; Poletti V; Granone P; Ricardi U; Novello S; Scotti V
PLoS One; 2019; 14(11):e0224027. PubMed ID: 31721773
[TBL] [Abstract][Full Text] [Related]
2. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology.
J Clin Oncol; 1997 Aug; 15(8):2996-3018. PubMed ID: 9256144
[TBL] [Abstract][Full Text] [Related]
3. Approach to the non-operative management of patients with stage II non-small cell lung cancer (NSCLC): A survey of Canadian medical and radiation oncologists.
Dudani S; Leighl NB; Ho C; Pantarotto JR; Zhu X; Zhang T; Wheatley-Price P
Lung Cancer; 2016 Apr; 94():74-80. PubMed ID: 26973210
[TBL] [Abstract][Full Text] [Related]
4. Treatment Decision Drivers in Stage III Non-Small-Cell Lung Cancer: Outcomes of a Web-Based Survey of Oncologists in the United States.
Cotarla I; Boron ML; Cullen SL; Spinner DS; Faulkner EC; Carroll MC; Shah S; Yagui-Beltran A
JCO Oncol Pract; 2020 Oct; 16(10):e1232-e1242. PubMed ID: 32552457
[TBL] [Abstract][Full Text] [Related]
5. Recent trends in the treatment of unresectable stage III non-small-cell lung cancer.
Makimoto G; Hotta K; Kiura K
Respir Investig; 2019 Jul; 57(4):330-336. PubMed ID: 31000495
[TBL] [Abstract][Full Text] [Related]
6. Combined modality therapy of early stage nonsmall cell lung cancer.
Pisters KM
Respir Care Clin N Am; 2003 Jun; 9(2):191-205. PubMed ID: 12911289
[TBL] [Abstract][Full Text] [Related]
7. Navigating Diagnostic and Treatment Decisions in Non-Small Cell Lung Cancer: Expert Commentary on the Multidisciplinary Team Approach.
Popat S; Navani N; Kerr KM; Smit EF; Batchelor TJP; Van Schil P; Senan S; McDonald F
Oncologist; 2021 Feb; 26(2):e306-e315. PubMed ID: 33145902
[TBL] [Abstract][Full Text] [Related]
8. Beliefs among pulmonologists and thoracic surgeons in the therapeutic approach to non-small cell lung cancer.
Schroen AT; Detterbeck FC; Crawford R; Rivera MP; Socinski MA
Chest; 2000 Jul; 118(1):129-37. PubMed ID: 10893370
[TBL] [Abstract][Full Text] [Related]
9. Stage III Non-small Cell Lung Cancer: A UK National Survey of Practice.
Evison M; Edwards J; McDonald F; Popat S
Clin Oncol (R Coll Radiol); 2020 Aug; 32(8):527-536. PubMed ID: 32216979
[TBL] [Abstract][Full Text] [Related]
10. Patterns of practice survey for nonsmall cell lung carcinoma in the U.S.
Choy H; Shyr Y; Cmelak AJ; Mohr PJ; Johnson DH
Cancer; 2000 Mar; 88(6):1336-46. PubMed ID: 10717614
[TBL] [Abstract][Full Text] [Related]
11. Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.
Califano R; Karamouzis MV; Banerjee S; de Azambuja E; Guarneri V; Hutka M; Jordan K; Kamposioras K; Martinelli E; Corral J; Postel-Vinay S; Preusser M; Porcu L; Torri V
Lung Cancer; 2014 Jul; 85(1):74-80. PubMed ID: 24746176
[TBL] [Abstract][Full Text] [Related]
12. Is multidisciplinary management possible in the treatment of lung cancer? A report from three Italian meetings.
Franceschini D; Bruni A; Borghetti P; Giaj-Levra N; Ramella S; Buffoni L; Badellino S; Andolina M; Comin C; Vattemi E; Bezzi M; Trovò M; Passaro A; Bearz A; Chiari R; Tindara F; Ferrari K; Piperno G; Filippi AR; Genovesi D; Scotti V
Radiol Med; 2020 Feb; 125(2):214-219. PubMed ID: 31605353
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group.
Logan DM; Lochrin CA; Darling G; Eady A; Newman TE; Evans WK
Cancer Prev Control; 1997 Dec; 1(5):366-78. PubMed ID: 9765759
[TBL] [Abstract][Full Text] [Related]
14. Radiation therapy in small cell lung cancer: a national Italian survey.
Ciammella P; Timon G; Bruni A; Franceschini D; Borghetti P; Giaj-Levra N; Greco C; Scotti V; Trovo M;
Radiol Med; 2018 Jul; 123(7):554-560. PubMed ID: 29536412
[TBL] [Abstract][Full Text] [Related]
15. Unmet Clinical Need in the Management of Locally Advanced Unresectable Lung Cancer: Treatment Strategies to Improve Patient Outcomes.
Rajappa S; Sharma S; Prasad K
Adv Ther; 2019 Mar; 36(3):563-578. PubMed ID: 30693419
[TBL] [Abstract][Full Text] [Related]
16. Non-small cell lung cancer, version 1.2015.
Ettinger DS; Wood DE; Akerley W; Bazhenova LA; Borghaei H; Camidge DR; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Dilling TJ; Govindan R; Grannis FW; Horn L; Jahan TM; Komaki R; Kris MG; Krug LM; Lackner RP; Lanuti M; Lilenbaum R; Lin J; Loo BW; Martins R; Otterson GA; Patel JD; Pisters KM; Reckamp K; Riely GJ; Rohren E; Schild S; Shapiro TA; Swanson SJ; Tauer K; Yang SC; Gregory K; Hughes M
J Natl Compr Canc Netw; 2014 Dec; 12(12):1738-61. PubMed ID: 25505215
[TBL] [Abstract][Full Text] [Related]
17. Trimodality therapy for stage IIIA non-small cell lung cancer: benchmarking multi-disciplinary team decision-making and function.
Dickhoff C; Hartemink KJ; van de Ven PM; van Reij EJ; Senan S; Paul MA; Smit EF; Dahele M
Lung Cancer; 2014 Aug; 85(2):218-23. PubMed ID: 24976333
[TBL] [Abstract][Full Text] [Related]
18. [Outcome of concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer patients].
Liu L; Wang X; Ji Z; Wang J; Bi N; Hui Z; Lyu J; Liang J; Zhou Z; Feng Q; Chen D; Zhang H; Xiao Z; Yin W; Wang L
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):863-7. PubMed ID: 26887520
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer treatment in New Zealand: physician's attitudes.
Christmas T; Findlay M
N Z Med J; 2004 Jun; 117(1196):U931. PubMed ID: 15280935
[TBL] [Abstract][Full Text] [Related]
20. Defining comprehensive biomarker-related testing and treatment practices for advanced non-small-cell lung cancer: Results of a survey of U.S. oncologists.
Mileham KF; Schenkel C; Bruinooge SS; Freeman-Daily J; Basu Roy U; Moore A; Smith RA; Garrett-Mayer E; Rosenthal L; Garon EB; Johnson BE; Osarogiagbon RU; Jalal S; Virani S; Weber Redman M; Silvestri GA
Cancer Med; 2022 Jan; 11(2):530-538. PubMed ID: 34921524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
